SCHEMBL16653274

SCHEMBL16653274

CCOC(=O)CC(=O)CSc1cc(=O)n(C)c(=O)n1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
ALDH1A1 P00352 6/20 0.46
HPGD P15428 5/20 0.46
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 4/20 0.44
HTT P42858 4/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
HSD17B10 Q99714 6/20 0.43
TSHR P16473 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16663491 0.82 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC6HDAC5
SCHEMBL16663488 0.81 NPSR1 (0.43) ALDH1A1HPGDKDM4EHTTMAPT
SCHEMBL7011885 0.80 MAPT (0.47) ALDH1A1HPGDKDM4EHTTMAPT
SCHEMBL20819193 0.69 ALDH1A1 (0.65) HDAC3HDAC1HDAC2HDAC6HDAC5
SCHEMBL9751601 0.68 HSD17B10 (0.59) HDAC3HDAC1HDAC2HDAC6HDAC5
SCHEMBL6421307 0.68 ALDH1A1 (0.54) HDAC3HDAC1HDAC2HDAC6HDAC5
SCHEMBL9550721 0.67 HDAC3 (0.48) HDAC3HDAC1HDAC2HDAC6HDAC5
SCHEMBL1722192 0.66 MEN1 (0.54) HDAC3HDAC1HDAC2HDAC6HDAC5
SCHEMBL7429124 0.66 SMN1; SMN2 (0.53) HDAC3HDAC1HDAC2HDAC6HDAC5
SCHEMBL10366553 0.66 NCOA1 (0.52) HDAC3HDAC1HDAC2HDAC6HDAC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858999-B1 AMIDES OF 2-AMINO-4-ARYLTHIAZOLE COMPOUNDS AND THEIR SALTS GLENMARK PHARMACEUTICALS SA (CH) 2017-05-10 EP disclosed
US-9458173-B2 Amides of 2-amino-4-arylthiazole compounds and their salts GLENMARK PHARMACEUTICALS S.A. (CH) 2016-10-04 US disclosed
US-20150111038-A1 AMIDES OF 2-AMINO-4-ARYLTHIAZOLE COMPOUNDS AND THEIR SALTS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150111038-A1 AMIDES OF 2-AMINO-4-ARYLTHIAZOLE COMPOUNDS AND THEIR SALTS AADAC, ABL2, ABL1 HDAC3 801/4885HDAC1 711/4885HDAC2 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.